diazooxonorleucine has been researched along with Obesity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Jiang, T; Jin, L; Li, C; Liu, B; Qin, X; Zheng, Q | 1 |
Ambrosius, WT; Considine, RV; Cooksey, RC; Fawcett, RL; Huse, J; Inman, M; Jones, R; McClain, DA; Whitfield, RM; Williams, LB; Zhang, P | 1 |
2 other study(ies) available for diazooxonorleucine and Obesity
Article | Year |
---|---|
Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity.
Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Diazooxonorleucine; Disease Models, Animal; Glycosylation; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Reperfusion Injury; Myocardium; Obesity; Protein Processing, Post-Translational; Rats | 2021 |
Hexosamines regulate leptin production in human subcutaneous adipocytes.
Topics: Adipocytes; Body Mass Index; Cells, Cultured; Diazooxonorleucine; Glucosamine; Hexosamines; Humans; In Vitro Techniques; Leptin; Obesity; Stimulation, Chemical; Uridine Diphosphate N-Acetylglucosamine | 2000 |